Women treated for female reproductive cancers (breast, uterine, ovarian or cervical cancers) Cancer Malignant neoplasm of breast, Malignant neoplasm of uterus, part unspecified, Malignant neoplasm of ovary, Malignant neoplasm of cervix uteri
Conditions
Interventions
Each participant will be randomly assigned either to an intervention group or a control group in 1:1 ratio using block randomisation.
Participants in the intervention group will receive a 12-week mul
new information and evidence will be posted on the website/app every day in the first three weeks, and then weekly for the following nine weeks. A research nurse will monitor participants’ page views
and (ii) engaging the participants to reflect on their belief, assumptions, knowledge and goals.
Participants in the control group will receive brief information on the follow-up schedule during base
Sponsors
Chinese University of Hong Kong
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Women with a primary diagnosis of female reproductive cancers (breast, uterine, ovarian or cervical cancers) 2. Within 3 months of completion of intensive cancer treatments (e.g. surgery, radiotherapy, and/or chemotherapy) but can be on maintenance therapies such as tamoxifen, trastuzumab and bisphosphonates 3. Over 18 years old 4. Able to understand spoken Cantonese and to read Chinese 5. Have internet-connected computing devices or smartphones
Exclusion criteria
Exclusion criteria: Those with unsuitable physical or mental health conditions, including visual impairment or pre-existing psychosis, will be excluded as their ability to comprehend information and answer questionnaires would be affected
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sense of coherence measured using the Chinese version of the Sense of Coherence 13-item Scale (CSOC-13) at baseline, completion of the intervention, and 12 weeks after completion | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Cancer-specific distress measured using the Chinese version of Impact of Events-Revised scale (CIES-R) ) at baseline, completion of the intervention, and 12 weeks after completion 2. Health-related quality of life measured using the Chinese version of the MOS 36-item Short Form (SF-36) Health Survey at baseline, completion of the intervention, and 12 weeks after completion 3. Participants' experiences, perceptions and opinions explored by semi-structured interviews upon completion of the intervention | — |
Countries
Hong Kong
Outcome results
None listed